AstraZeneca released updated information on its COVID-19 clinical trial Wednesday evening, showing an effectiveness rate of 76% instead of the 79% rate it claimed earlier in the week.
AstraZeneca released updated information on its COVID-19 clinical trial Wednesday evening, showing an effectiveness rate of 76% instead of the 79% rate it claimed earlier in the week.